Mynaric AG Net Assets

Latest as of December 2023: €-49.29 Million EUR ≈ $-57.62 Million USD

Mynaric AG net assets. Based on the latest financial reports, Mynaric AG (M0YN) has net assets worth €-49.29 Million EUR (≈ $-57.62 Million USD) as of December 2023. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€119.09 Million ≈ $139.22 Million USD) and total liabilities (€168.37 Million ≈ $196.85 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore how fast is Mynaric AG growing its equity to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric Value
Current Net Assets €-49.29 Million
% of Total Assets -41.39%
Annual Growth Rate N/A
5-Year Change -326.71%
10-Year Change -16696.46%
Growth Volatility 3396.38

Net Assets of Mynaric AG (2013–2023)

Net assets of Mynaric AG from 2013 to 2023. This chart illustrates how Mynaric AG's net assets have evolved over time, based on quarterly financial data. See Mynaric AG balance sheet quality to measure how much of total assets are equity-financed.

Annual Net Assets for Mynaric AG (2013–2023)

The table below shows the annual net assets of Mynaric AG from 2013 to 2023. For live market cap and overall valuation, see M0YN market cap.

Year Net Assets Change
2023-12-31 €-49.29 Million
≈ $-57.62 Million
-277.34%
2022-12-31 €27.79 Million
≈ $32.49 Million
-67.27%
2021-12-31 €84.91 Million
≈ $99.27 Million
+20.09%
2020-12-31 €70.71 Million
≈ $82.67 Million
+225.24%
2019-12-31 €21.74 Million
≈ $25.42 Million
-1.35%
2018-12-31 €22.04 Million
≈ $25.76 Million
-26.60%
2017-12-31 €30.02 Million
≈ $35.10 Million
+11370.44%
2016-12-31 €261.72K
≈ $305.98K
-82.30%
2015-12-31 €1.48 Million
≈ $1.73 Million
+397.98%
2014-12-31 €296.97K
≈ $347.19K
+458.43%
2013-12-31 €53.18K
≈ $62.17K
--

Equity Component Analysis

This analysis shows how different components contribute to Mynaric AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 19067328.7% over the analyzed period, potentially due to dividend distributions or operating losses.

Mynaric AG Net Assets Breakdown (December 2023)

Mynaric AG net assets breakdown by equity component as of December 2023.

Component Amount Percentage
Common Stock €6.23 Million %
Other Comprehensive Income €531.00K %
Other Components €204.03 Million %
Total Equity €-49.29 Million 100.00%

Mynaric AG Competitors by Market Cap

The table below lists competitors of Mynaric AG ranked by their market capitalization.

Company Market Cap
Marula Mining PLC
F:48U0
$3.36 Million
Thrive Tribe Technologies Ltd
AU:1TT
$3.36 Million
Inomin Mines Inc
V:MINE
$3.37 Million
Colipays Reunion SA
PA:MLCLP
$3.37 Million
PT Trimuda Nuansa Citra Tbk
JK:TNCA
$3.36 Million
Summit Minerals Ltd
AU:SUM
$3.36 Million
Terra Uranium Ltd
AU:T92
$3.36 Million
NextEnergy Solar Fund Ltd
LSE:NESF
$3.36 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Mynaric AG's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2022 to 2023, total equity changed from 27,793,000 to -49,287,000, a change of -77,080,000 (-277.3%).
  • Net loss of 93,528,000 reduced equity.
  • New share issuances of 12,769,000 increased equity.
  • Other comprehensive income increased equity by 1,126,000.
  • Other factors increased equity by 2,553,000.

Equity Change Factors (2022 to 2023)

Factor Impact Contribution
Net Income €-93.53 Million -189.76%
Share Issuances €12.77 Million +25.91%
Other Comprehensive Income €1.13 Million +2.28%
Other Changes €2.55 Million +5.18%
Total Change €- -277.34%

Book Value vs Market Value Analysis

This analysis compares Mynaric AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2013-12-31 €0.01 €0.53 x
2014-12-31 €0.00 €0.53 x
2015-12-31 €0.55 €0.53 x
2016-12-31 €0.10 €0.53 x
2017-12-31 €11.10 €0.53 x
2018-12-31 €8.15 €0.53 x
2019-12-31 €7.49 €0.53 x
2020-12-31 €21.11 €0.53 x
2021-12-31 €19.98 €0.53 x
2022-12-31 €5.11 €0.53 x
2023-12-31 €-8.16 €0.53 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Mynaric AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -1735.21%
  • • Asset Turnover: 0.05x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-109.39%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2013 9.84% 2.30% 0.11x 37.92x €-41.40
2014 0.00% -15.12% 0.81x 0.00x €-195.83K
2015 -56.85% -45.31% 1.07x 1.18x €-988.67K
2016 -704.18% -362.07% 0.26x 7.42x €-1.87 Million
2017 -23.05% -236.32% 0.09x 1.05x €-9.92 Million
2018 -35.30% -172.17% 0.18x 1.12x €-9.98 Million
2019 -45.52% -8680.70% 0.00x 1.45x €-12.07 Million
2020 -29.19% -3040.06% 0.01x 1.29x €-27.71 Million
2021 -53.56% -1931.08% 0.02x 1.32x €-53.97 Million
2022 -265.47% -1668.52% 0.05x 3.02x €-76.56 Million
2023 0.00% -1735.21% 0.05x 0.00x €-88.60 Million

Industry Comparison

This section compares Mynaric AG's net assets metrics with peer companies in the same industry.

Industry Context

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Mynaric AG (M0YN) €-49.29 Million 9.84% N/A $3.36 Million
Covestro AG (1COV) $6.68 Billion -3.98% 1.04x $11.10 Billion
CENTESSA PHARMACEUTICALS (260) $401.55 Million -58.71% 0.44x $5.35 Billion
2invest AG (2INV) $61.58 Million -34.16% 0.01x $70.69 Million
COINSHARES I. LS-000247 (3TW) $-1.41K 0.00% 0.00x $472.53 Million
Adaptimmune Therapeutics plc (473A) $123.64 Million -110.94% 0.47x $42.94 Million
KINGMAN MINERALS LTD. (47A) $1.72 Million -14.34% 0.35x $4.05K
GENOR BIOPHARMA DL-00002 (67N0) $2.49 Billion -34.70% 0.15x $93.97 Million
BENO Holding AG (BENH) $16.45 Million 13.33% 2.75x $72.92K
Biotest Aktiengesellschaft (BIO) $253.37 Million 11.10% 1.34x $976.15 Million
Biotest Aktiengesellschaft (BIO3) $110.79 Million 17.87% 2.36x $656.94 Million

About Mynaric AG

XETRA:M0YN Germany
Market Cap
$3.93 Million
€3.36 Million EUR
Market Cap Rank
#29261 Global
#2531 in Germany
Share Price
€0.53
Change (1 day)
+0.00%
52-Week Range
€0.53 - €0.53
All Time High
€86.00
About

Mynaric AG develops and manufactures laser communication products for aerospace-based communication networks for government and commercial markets in the United States and internationally. It operates through Air and Space segments. The company's laser communication technology provides long-distance data transmission between moving objects for wireless space, airborne, and terrestrial application… Read more